Market Cap

SK Biopharmaceuticals Co. Ltd Market Capitalization:

₩9.625 Trillion

KRW as of Jan. 1, 2026

US$6.67 Billion

business SK Biopharmaceuticals Co. Ltd Company Profile

SK Biopharmaceuticals Co. Ltd Main Stock Listing

KRX: 326030

Market Capitalization History of SK Biopharmaceuticals Co. Ltd

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of SK Biopharmaceuticals Co. Ltd market cap

Date Market Cap YoY Change
Jan. 1, 2026 ₩9.625 T 12.03%
Jan. 1, 2025 ₩8.591 T 12.86%
Jan. 1, 2024 ₩7.612 T 38.86%
Jan. 1, 2023 ₩5.482 T -6.46%
Jan. 1, 2022 ₩5.861 T -47.72%
Jan. 1, 2021 ₩11.211 T

Market capitalization is calculated from the opening stock price at the beginning of each year.

SK Biopharmaceuticals Co. Ltd Categories

South Korea languages Healthcare languages Biotechnology
South Korea Healthcare South Korea Biotechnology

Stocks & Indices

SK Biopharmaceuticals Co. Ltd has the following listings and related stock indices.


Stock: KRX: 326030

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.